Sleep Apnea, Sleep Duration and Brain MRI Markers of Cerebral Vascular Disease and Alzheimer's Disease: The Atherosclerosis Risk in Communities Study (ARIC)

Pamela L Lutsey, Faye L Norby, Rebecca F Gottesman, Thomas Mosley, Richard F MacLehose, Naresh M Punjabi, Eyal Shahar, Clifford R Jack Jr, Alvaro Alonso, Pamela L Lutsey, Faye L Norby, Rebecca F Gottesman, Thomas Mosley, Richard F MacLehose, Naresh M Punjabi, Eyal Shahar, Clifford R Jack Jr, Alvaro Alonso

Abstract

Background: A growing body of literature has suggested that obstructive sleep apnea (OSA) and habitual short sleep duration are linked to poor cognitive function. Neuroimaging studies may provide insight into this relation.

Objective: We tested the hypotheses that OSA and habitual short sleep duration, measured at ages 54-73 years, would be associated with adverse brain morphology at ages 67-89 years.

Methods: Included in this analysis are 312 ARIC study participants who underwent in-home overnight polysomnography in 1996-1998 and brain MRI scans about 15 years later (2012-2013). Sleep apnea was quantified by the apnea-hypopnea index and categorized as moderate/severe (≥15.0 events/hour), mild (5.0-14.9 events/hour), or normal (<5.0 events/hour). Habitual sleep duration was categorized, in hours, as <7, 7 to <8, ≥8. MRI outcomes included number of infarcts (total, subcortical, and cortical) and white matter hyperintensity (WMH) and Alzheimer's disease signature region volumes. Multivariable adjusted logistic and linear regression models were used. All models incorporated inverse probability weighting, to adjust for potential selection bias.

Results: At the time of the sleep study participants were 61.7 (SD: 5.0) years old and 54% female; 19% had moderate/severe sleep apnea. MRI imaging took place 14.8 (SD: 1.0) years later, when participants were 76.5 (SD: 5.2) years old. In multivariable models which accounted for body mass index, neither OSA nor abnormal sleep duration were statistically significantly associated with odds of cerebral infarcts, WMH brain volumes or regional brain volumes.

Conclusions: In this community-based sample, mid-life OSA and habitually short sleep duration were not associated with later-life cerebral markers of vascular dementia and Alzheimer's disease. However, selection bias may have influenced our results and the modest sample size led to relatively imprecise associations.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

References

    1. Ortman JM, Velkoff VA, Hogan H. An aging nation: The older population in the United States U.S. Census Bureau, 2014.
    1. United Nations Department of Economic and Social Affairs, Population Division. World Population Aging. United Nations, 2013.
    1. 2015 Alzheimer's disease facts and figures. Alzheimers Dement. 2015;11(3):332–84. .
    1. Fitzpatrick AL, Kuller LH, Ives DG, Lopez OL, Jagust W, Breitner JCS, et al. Incidence and prevalence of dementia in the cardiovascular health study. J Am Geriatr Soc. 2004;52(2):195–204.
    1. Amlander C, Fuller P. Basics of Sleep Guide. Society SR, ed. Westchester, Illinois: Sleep Research Society; 2009.
    1. Yaffe K, Laffan AM, Harrison SL, Redline S, Spira AP, Ensrud KE, et al. Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA. 2011;306(6):613–9. PubMed Central PMCID: 10.1001/jama.2011.1115
    1. Bliwise DL. Sleep apnea, APOE4 and Alzheimer's disease 20 years and counting? J Psychosom Res. 2002;53(1):539–46.
    1. Durgan DJ, Bryan RM. Cerebrovascular consequences of obstructive sleep apnea.J Am Heart Assoc. 2012;1(4):e000091 PubMed Central PMCID: 10.1161/JAHA.111.000091
    1. Redline S, Yenokyan G, Gottlieb DJ, Shahar E, O'Connor GT, Resnick HE, et al. Obstructive sleep apnea–hypopnea and incident stroke: The Sleep Heart Health J Respir Crit Care Med. 2010;182(2):269–77. PubMed Central PMCID: PMC2913239 10.1164/rccm.200911-1746OC
    1. Placidi F, Diomedi M, Cupini LM, Bernardi G, Silvestrini M. Impairment of daytime cerebrovascular reactivity in patients with obstructive sleep apnoea syndrome. J Sleep Res. 1998;7(4):288–92.
    1. Buratti L, Viticchi G, Falsetti L, Cagnetti C, Luzzi S, Bartolini M, et al. Vascular impairment in Alzheimer's disease: the role of obstructive sleep apnea. J Alzheimers Dis. 2014;38(2):445–53. 10.3233/JAD-131046
    1. Born J, Wilhelm I. System consolidation of memory during sleep. Psychol Res. 2012;76(2):192–203. PubMed Central PMCID: PMC3278619 10.1007/s00426-011-0335-6
    1. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. New England Journal of Medicine. 2005;353(19):2034–41.
    1. Munoz R, Duran-Cantolla J, Martínez-Vila E, Gallego J, Rubio R, Aizpuru F, et al. Severe sleep apnea and risk of iIschemic stroke in the elderly. Stroke. 2006;37(9):2317–21.
    1. Knopman DS, Griswold ME, Lirette ST, Gottesman RF, Kantarci K, Sharrett AR, et al. Vascular imaging abnormalities and cognition: Mediation by cortical volume in nondemented individuals: Atherosclerosis Risk in Communities-Neurocognitive Study. Stroke. 2015;46(2):433–40. PubMed Central PMCID: PMC4308430 10.1161/STROKEAHA.114.007847
    1. Kang JE, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR, et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science. 2009;326(5955):1005–7. PubMed Central PMCID: PMC2789838. 10.1126/science.1180962
    1. Kadotani H, Kadotani T, Young T, Peppard PE, Finn L, Colrain IM, et al. Association between apolipoprotein e ∊4 and sleep-disordered breathing in adults. JAMA. 2001;285(22):2888–90. .
    1. Gottlieb DJ, DeStefano AL, Foley DJ, Mignot E, Redline S, Givelber RJ, et al. APOE epsilon4 is associated with obstructive sleep apnea/hypopnea: the Sleep Heart Health Study. Neurology. 2004;63(4):664–8. .
    1. Harbison J, Gibson GJ, Birchall D, Zammit–Maempel I, Ford GA. White matter disease and sleep-disordered breathing after acute stroke. Neurology. 2003;61(7):959–63. .
    1. Macey PM, Henderson LA, Macey KE, Alger JR, Frysinger RC, Woo MA, et al. Brain morphology associated with obstructive sleep apnea. Am J Respir Crit Care Med. 2002;166(10):1382–7. .
    1. Macey PM, Kumar R, Woo MA, Valladares EM, Yan-Go FL, Harper RM. Brain structural changes in obstructive sleep apnea. Sleep. 2008;31(7):967–77. PubMed PMCID:
    1. Joo EY, Tae WS, Lee MJ, Kang JW, Park HS, Lee JY, et al. Reduced brain gray matter concentration in patients with obstructive sleep apnea syndrome. Sleep. 2010;33(2):235–41. PubMed Central PMCID: PMC2817910.
    1. Canessa N, Castronovo V, Cappa SF, Aloia MS, Marelli S, Falini A, et al. Obstructive sleep apnea: Brain structural changes and neurocognitive function before and after treatment. Am J Respir Crit Care Med. 2011;183(10):1419–26. 10.1164/rccm.201005-0693OC
    1. Torelli F, Moscufo N, Garreffa G, Placidi F, Romigi A, Zannino S, et al. Cognitive profile and brain morphological changes in obstructive sleep apnea. NeuroImage. 2011;54(2):787–93. PubMed Central PMCID: PMC 4169712 10.1016/j.neuroimage.2010.09.065
    1. Yaouhi K, Bertran F, Clochon P, Mezenge F, Denise P, Foret J, et al. A combined neuropsychological and brain imaging study of obstructive sleep apnea. Journal of Sleep Research. 2009;18(1):36–48. 10.1111/j.1365-2869.2008.00705.x
    1. Eguchi K, Kario K, Hoshide S, Ishikawa J, Morinari M, Shimada K. Nocturnal hypoxia is associated with silent cerebrovascular disease in a high-risk Japanese community-dwelling population. Am J Hypertens. 2005;18(11):1489–95.
    1. Nishibayashi M, Miyamoto M, Miyamoto T, Suzuki K, Hirata K. Correlation between severity of obstructive sleep apnea and prevalence of silent cerebrovascular lesions. J Clin Sleep Med. 2008;4(3):242–7. PubMed Central PMCID: PMC2546457.
    1. Investigators. The Atherosclerosis Risk in Communities (ARIC) study: Design and objectives. Am J Epidemiol. 1989;129(4):687–702.
    1. Quan SF, Howard BV, Iber C, Kiley JP, Nieto FJ, O'Connor GT, et al. The Sleep Heart Health Study: design, rationale, and methods. Sleep. 1997;20(12):1077–85..
    1. Weuve J, Tchetgen Tchetgen EJ, Glymour MM, Beck TL, Aggarwal NT, Wilson RS, et al. Accounting for bias due to selective attrition: The example of smoking and cognitive decline. Epidemiology. 2012;23(1):119–28. PubMed Central PMCID: PMC 3237815 10.1097/EDE.0b013e318230e861
    1. Gottesman RF, Rawlings AM, Sharrett AR, Albert M, Alonso A, Bandeen-Roche K, et al. Impact of differential attrition on the association of education with cognitive change over 20 years of follow-up: The ARIC Neurocognitive Study. Am J Epidemiol. 2014;179(8):956–66. PubMed Central PMCID: PMC3966720. 10.1093/aje/kwu020
    1. Redline S, Sanders MH, Lind BK, Quan SF, Iber C, Gottlieb DJ, et al. Methods for obtaining and analyzing unattended polysomnography data for a multicenter study. Sleep Heart Health Research Group. Sleep. 1998;21(7):759–67. .
    1. Jack CR, O'Brien PC, Rettman DW, Shiung MM, Xu Y, Muthupillai R, et al. FLAIR histogram segmentation for measurement of leukoaraiosis volume. J Magn Reson Imaging. 2001;14(6):668–76. PubMed Central PMCID: PMC 2755497
    1. Raz L, Jayachandran M, Tosakulwong N, Lesnick TG, Wille SM, Murphy MC, et al. Thrombogenic microvesicles and white matter hyperintensities in postmenopausal women. Neurology. 2013;80(10):911–8. PubMed PMCID: 10.1212/WNL.0b013e3182840c9f
    1. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12(8):822–38. PubMed PMCID: 10.1016/S1474-4422(13)70124-8
    1. Kantarci K, Weigand SD, Przybelski SA, Shiung MM, Whitwell JL, Negash S, et al. Risk of dementia in MCI: Combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS. Neurology. 2009;72(17):1519–25. PubMed Central PMCID: PMC2843530. 10.1212/WNL.0b013e3181a2e864
    1. Fischl B, Salat DH, Busa E, Albert M, Dieterich M, Haselgrove C, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33(3):341–55.
    1. Pathan SS, Gottesman RF, Mosley TH, Knopman DS, Sharrett AR, Alonso A. Association of lung function with cognitive decline and dementia: the Atherosclerosis Risk in Communities (ARIC) Study. Eur J Neurol. 2011;18(6):888–98. PubMed Central PMCID: PMC3092022 10.1111/j.1468-1331.2010.03340.x
    1. Staessen JA, Richart T, Birkenhäger WH. Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brain. Hypertens. 2007;49(3):389–400. .
    1. Gottesman RF, Schneider AC, Albert M, Alonso A, Bandeen-Roche K, Coker L, et al. Midlife hypertension and 20-year cognitive change: The Atherosclerosis Risk in Communities Neurocognitive Study. JAMA Neurology. 2014;71(10):1218–27. PubMed Central PMCID: PMC4226067. 10.1001/jamaneurol.2014.1646
    1. Alonso A, Mosley TH, Gottesman RF, Catellier D, Sharrett AR, Coresh J. Risk of dementia hospitalisation associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis Risk in Communities (ARIC) study.J Neurol Neurosurg Psychiatry. 2009;80(11):1194–201. PubMed Central PMCID: PMC2783764 10.1136/jnnp.2009.176818
    1. Elias PK, Elias MF, D'Agostino RB, Cupples LA, Wilson PW, Silbershatz H, et al. NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study. Diab Care. 1997;20(9):1388–95. .
    1. Gregg EW, Yaffe K, Cauley JA, Rolka DB, Blackwell TL, Narayan KM, et al. Is diabetes associated with cognitive impairment and cognitive decline among older women? Arch Int Med. 2000;160(2):174–80. .
    1. Logroscino G, Kang JH, Grodstein F. Prospective study of type 2 diabetes and cognitive decline in women aged 70–81 years. BMJ. 2004;328(7439):548 PubMed Central PMCID: PMC381043.
    1. Rawlings AM, Sharrett AR, Schneider ALC, Coresh J, Albert M, Couper D, et al. Diabetes in midlife and cognitive change over 20 years: A cohort study. Ann Intern Med. 2014;161(11):785–93. PubMed Central PMCID: PMC4432464. 10.7326/M14-0737
    1. Hernan MA, Alonso A, Logroscino G. Cigarette smoking and dementia: potential selection bias in the elderly. Epidemiology. 2008;19(3):448–50. 10.1097/EDE.0b013e31816bbe14
    1. Kalaria RN, Spoors L, Laude EA, Emery CJ, Thwaites-Bee D, Fairlie J, et al. Hypoxia of sleep apnoea: cardiopulmonary and cerebral changes after intermittent hypoxia in rats. Respir Physiol Neuribiol. 2004;140(1):53–62. .
    1. Xu W, Chi L, Row BW, Xu R, Ke Y, Xu B, et al. Increased oxidative stress is associated with chronic intermittent hypoxia-mediated brain cortical neuronal cell apoptosis in a mouse model of sleep apnea. Neuroscience. 2004;126(2):313–23. .
    1. Tung A, Takase L, Fornal C, Jacobs B. Effects of sleep deprivation and recovery sleep upon cell proliferation in adult rat dentate gyrus. Neuroscience. 2005;134(3):721–3. .
    1. Nair D, Zhang SXL, Ramesh V, Hakim F, Kaushal N, Wang Y, et al. Sleep fragmentation induces cognitive deficits via nicotinamide adenine dinucleotide phosphate cxidase–dependent pathways in mouse. Am J Respir Crit Care Med. 2011;184(11):1305–12. PubMed Central PMCID: PMC3262045. 10.1164/rccm.201107-1173OC
    1. Lutsey PL, Bengtson LG, Punjabi NM, Shahar E, Mosley TH, Gottesman RF, et al. Obstructive Sleep Apnea and 15-Year Cognitive Decline: The Atherosclerosis Risk in Communities (ARIC) Study. Sleep. 2015;38(6):877–88 PubMed Central PMCID: PMC4434554
    1. Cole SR, Hernán MA. Constructing Inverse Probability Weights for Marginal Structural Models. Am J Epidemiol. 2008;168(6):656–64. PubMed PMCID: 10.1093/aje/kwn164

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다